ARCHIVES

Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin

This article is from The Cancer Letter archive.

Vol. 36 No. 28 | July 23, 2010

Download PDF Visit The Full Archive

Related Articles

Paul Okunieff Named Director At UF Shands Cancer Center

October 16, 2009

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

December 30, 2011

In Brief: FDA Cool To Committee Review of INDs; New Commissioner Is Donald Kennedy, Of Stanford

March 11, 1977

NCI plans to cut staff access to The Cancer Letter; insiders allege attempt at “thought control.”

November 18, 2005

In Brief: Freireich On Nutrition: Diet Can Affect Immune System, Effectiveness Of Cancer Drugs

September 12, 1975

No Recision Seen, New Money To Low In Mid-March

February 20, 1976